Solventum (NYSE:SOLV) Shares Unloaded Sen. Ron Wyden

Senator Ron Wyden (D-Oregon) recently sold shares of Solventum Co. (NYSE:SOLV). In a filing disclosed on February 21st, the Senator disclosed that they had sold between $1,001 and $15,000 in Solventum stock on February 6th.

Senator Ron Wyden also recently made the following trade(s):

• Sold $50,001 – $100,000 in shares of Eli Lilly and Company (NYSE:LLY) on 2/10/2025.
• Sold $1,001 – $15,000 in shares of iRobot (NASDAQ:IRBT) on 2/6/2025.
• Purchased $50,001 – $100,000 in shares of Eli Lilly and Company (NYSE:LLY) on 1/22/2025.

Solventum Price Performance

SOLV opened at $73.08 on Friday. The company’s 50 day moving average is $71.14 and its 200-day moving average is $69.15. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

Analyst Ratings Changes

SOLV has been the topic of several recent research reports. Mizuho initiated coverage on shares of Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price on the stock. Piper Sandler lifted their target price on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Finally, Morgan Stanley lifted their target price on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, Solventum presently has an average rating of “Hold” and a consensus target price of $68.29.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Modus Advisors LLC acquired a new position in shares of Solventum in the 4th quarter worth approximately $25,000. Clarity Asset Management Inc. acquired a new position in shares of Solventum in the 4th quarter worth approximately $25,000. Stonebridge Financial Group LLC acquired a new position in shares of Solventum in the 4th quarter worth approximately $26,000. Raiffeisen Bank International AG acquired a new position in shares of Solventum in the 4th quarter worth approximately $29,000. Finally, Crews Bank & Trust acquired a new position in shares of Solventum in the 4th quarter worth approximately $32,000.

About Senator Wyden

Ron Wyden (Democratic Party) is a member of the U.S. Senate from Oregon. He assumed office on January 30, 1996. His current term ends on January 3, 2029. Wyden (Democratic Party, Independent Party) ran for re-election to the U.S. Senate to represent Oregon. He won in the general election on November 8, 2022. He advanced from the Democratic primary on May 17, 2022. In 2018, the Town Hall Project, which described itself as “a citizen powered, grassroots effort that empowers constituents across the country to have face-to-face conversations with their elected representatives,” named Wyden town hall MVP for the second year in a row. According to OregonLive, Wyden held over 900 town hall meetings between 1996 and 2018. Wyden previously served in the U.S. House of Representatives, representing Oregon’s 3rd Congressional District from 1981 to 1996. As of a 2014 analysis of multiple outside rankings, Wyden is an average Democratic member of Congress, meaning he will vote with the Democratic Party on the majority of bills.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.